country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Country or Region:

United States

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

Art. -Nr.: HY-W650831

Copy Link Print Information

Nithiazide

Nithiazide is an anti-histomonad agent with activity against Histomonas. Nithiazide does not cause macroscopic or histopathological abnormalities in the visceral organs of turkeys and chickens at specified doses and durations. Nithiazide induces tumor formation in multiple organs of rodents. Nithiazide can be used in research related to enterohepatitis and tumors, such as breast tumors, skin fibroadenomas, cystadenomas, liver tumors, etc.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

CAS. Nr.: 139-94-6
Formel: C₆H₈N₄O₃S
Molecular Weight:216.22

Speicherung:

Please store the product under the recommended conditions in the Certificate of Analysis.

Nithiazide Chemical Structure

CAS. Nr.: 139-94-6

Größe

Preis

Verfügbarkeit

Menge

Amount: USD 0.00

* Bitte wählen Sie Menge, bevor Sie Artikel hinzufügen.

Use of MCE Products

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Biologische Aktivität
- Beschreibung
- In Vitro
- In Vivo
Chemical Information
Reinheit & Dokumentation
Verweise
Calculators
Help & FAQs
Classifications
Bioz

Biologische Aktivität

Beschreibung

Alle Parasite Isoform-spezifische Produkte anzeigen :

In Vitro

Nithiazide exhibits genotoxic activity, testing positive in both the Ames Salmonella mutagenesis assay and the Chinese hamster ovary cell chromosomal abnormality assay^[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

In Vivo

The acute toxicity of single-dose Nithiazide (400-6400 mg/kg; p.o., single administration) is much lower than that of other nitrothiazole drugs. Even at the ultra-high dose of 6400 mg/kg, it does not cause death, but only induces mild growth inhibition^[1].
Nithiazide (added to feed at 0.05-0.2%; administered via ad libitum oral feeding for 21 days) exerts no significant adverse effects on the growth of turkeys^[1].
Nithiazide (added to feed at a ratio of 0.0062-0.4% and administered via ad libitum oral feeding for 21 days) has a safe feeding window (≤0.05%); dose-dependent growth inhibition occurs beyond this threshold, but no lethal toxicity is observed^[1].
Nithiazide (added to feed at a proportion of 0.0125-0.1%, administered via ad libitum oral feeding for 11-27 weeks) exerts no effect on the growth or feed conversion rate of turkeys at a treatment-related dietary level (≤0.1%) with long-term feeding^[1].
Nithiazide (added to feed at concentrations of 0.0125-0.1%; administered orally; ad libitum feeding; continuous dosing until egg laying ceases at 62-63 weeks) at standard therapeutic doses does not impair the reproductive performance of turkeys, and only the highest tested concentration slightly delays sexual maturity and reduces egg weight^[1].
Nithiazide (added to feed at a proportion of 0.05-0.28%, administered via ad libitum oral feeding for 14-19 weeks) has far weaker egg-suppressive toxicity than ANT/ACT; White Leghorn hens are more sensitive to nitrothiazole toxicity^[1].
Nithiazide (feed) exhibits in vivo carcinogenic activity in rodents, and induces tumorigenesis in three distinct organs of male and female rats and mice^[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:

White Rock chicks and Beltsville White turkeys (2-week-old)
^[1]
Dosage:

400 mg/kg; 800 mg/kg; 1600 mg/kg; 3200 mg/kg; 6400 mg/kg
Administration:

p.o.; single dose
Result:

Zero mortality in chicks and poults for all Nithiazide doses (400–6400 mg/kg).
3200 mg/kg showed no growth retardation; 6400 mg only mild growth suppression (chick 86%, poult 96% of control weight gain).
ANT caused death starting at 400 mg/kg, 100% chick mortality at 800 mg; ACT was far more toxic than Nithiazide.

Animal Model:

2-week-old poults^[1]
Dosage:

0.05%; 0.1%; 0.2%
Administration:

p.o.; ad libitum for 21 days
Result:

Showed no effect on chick growth with continuous feeding of 0.0062% to 0.05% nithiazide in feed.
Caused linear dose-response growth retardation with continuous feeding of 0.1% to 0.4% concentrations, with 0.2% reducing growth to ~50% of normal, and 0.4% causing considerable growth retardation with 0% mortality.

Animal Model:

White Rock chicks (3-day-old)^[1]
Dosage:

0.0062%; 0.0125%; 0.025%; 0.05%; 0.1%; 0.2%; 0.4%
Administration:

p.o.; ad libitum for 21 days
Result:

Low doses 0.0062%–0.05% showed no difference in chick weight vs control;
Linear growth suppression starting at ≥0.1%; 0.2% reduced body weight to half of control;
No mortality even at maximum 0.4% feed content, only severe stunting.

Animal Model:

Mixed-sex White Holland poults^[1]
Dosage:

0.0125%; 0.025%; 0.05%; 0.1%
Administration:

p.o.; ad libitum for 11-27 weeks
Result:

0.0125%–0.1% Nithiazide fed for 11/27 weeks produced no significant negative impacts on turkey weight or feed efficiency.

Animal Model:

27-week mature turkeys^[1]
Dosage:

0.0125%; 0.025%; 0.05%; 0.1%
Administration:

p.o.; ad libitum; continuous medication until egg production ceased at 62–63 weeks
Result:

Showed no adverse effects on body weight, egg production, fertility or hatchability at 0.0125%-0.05%.
Slightly delayed sexual maturity and mildly reduced egg weight, fertility unchanged at 0.1%.

Animal Model:

Mature White Leghorn and New Hampshire laying hens^[1]
Dosage:

0.05%; 0.1%; 0.14%; 0.2%; 0.28%
Administration:

p.o.; ad libitum for 14-19 weeks
Result:

Fed to White Leghorns for 14 weeks caused no obvious egg production drop at 0.05% & 0.1%.
New Hampshire hens had higher tolerance; 0.1-0.28% Nithiazide for 19 weeks did not interfere with laying.

Chemical Information

CAS. Nr. 139-94-6
Molecular Weight 216.22
Formel C₆H₈N₄O₃S
SMILES

O=C(NC1=NC=C([N+]([O-])=O)S1)NCC
Versand

Room temperature in continental US; may vary elsewhere.
Speicherung

Please store the product under the recommended conditions in the Certificate of Analysis.

Reinheit & Dokumentation

Handling Instructions (2659 KB)

Verweise

[1]. Cuckler AC, et al. Nithiazide: 3. Tolerance Studies in Poultry. Poult Sci. 1957;36(3):529-536.

[2]. Albert RE, et al. Allergic contact sensitizing chemicals as environmental carcinogens. Environmental health perspectives. 1997 Sep;105(9):940-8. [Content Brief]

Calculators

Molaritätsrechner

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Konzentration Konzentration

Volumen Volumen

Molecular Weight Molecular Weight

Verdünnungsrechner

Konzentration _{(Stammlösung)} × Volumen _{(Stammlösung)} = Konzentration _{(Ziellösung)} × Volumen _{(Ziellösung)}

Konzentration _{(Stammlösung)} Konzentration _{(Stammlösung)}

Volumen _{(Stammlösung)} Volumen _{(Stammlösung)}

Konzentration _{(Ziellösung)} Konzentration _{(Ziellösung)}

Volumen _{(Ziellösung)} Volumen _{(Ziellösung)}

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Bioz

Keywords

MOQ

Minimum order quantity

100 mg

Angebot einholen Auf Lager

Other size

Angebot einholen

Amount: USD 0.00

Biologische Aktivität
- Beschreibung
- In Vitro
- In Vivo
Chemical Information
Reinheit & Dokumentation
Verweise

Produktname:
Art. -Nr.:
Menge:
MCE Japan Authorized Agent:

Produktname:
CAS. Nr.:
Species:
Reinheit:
Menge:

Nithiazide

Alle Parasite Isoform-spezifische Produkte anzeigen